Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IB/IIA Study of Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in the Setting of Crohn's Disease.

NCT04519697 is registered in ClinicalTrials.gov with Anthony Lembo as lead sponsor.

NCT NCT04519697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04519697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IB/IIA Study of Adult Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in the Setting of Crohn's Disease.
Lead sponsor
Anthony Lembo
Phase
Phase 1/2
Overall status
Terminated
Start date
October 28, 2020
Completion date
November 15, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, crohn disease of vulva, rectolabial; fistula, rectovaginal fistula